| Literature DB >> 35619097 |
Rebecca Walwyn1, Robbie Foy2, Alexandra Wright-Hughes3, Thomas A Willis2, Stephanie Wilson4, Ana Weller4, Fabiana Lorencatto5, Mohamed Althaf4, Valentine Seymour4, Amanda J Farrin1, Jillian Francis6,7, Jamie Brehaut7,8, Noah Ivers9, Sarah L Alderson2, Benjamin C Brown10,11, Richard G Feltbower12, Chris P Gale12,13,14, Simon J Stanworth15,16,17,18, Suzanne Hartley1, Heather Colquhoun19, Justin Presseau7,8.
Abstract
BACKGROUND: Audit and feedback aims to improve patient care by comparing healthcare performance against explicit standards. It is used to monitor and improve patient care, including through National Clinical Audit (NCA) programmes in the UK. Variability in effectiveness of audit and feedback is attributed to intervention design; separate randomised trials to address multiple questions about how to optimise effectiveness would be inefficient. We evaluated different feedback modifications to identify leading candidates for further "real-world" evaluation.Entities:
Keywords: Audit and feedback; Behaviour change; MOST; Randomised fractional factorial experiment
Mesh:
Year: 2022 PMID: 35619097 PMCID: PMC9137082 DOI: 10.1186/s13012-022-01208-5
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.960
The six feedback modifications selected in our online fractional factorial screening experiment
| Modification description | Modification ON vs OFF |
|---|---|
Feedback is typically given in the context of a comparator. Select comparators according to their ability to change or reinforce the desired behaviour | ON when showing the top 25% nationally as the comparator OFF when showing the mean average |
Present feedback in different ways to help recipients develop a more memorable mental model of the information presented, allow interaction with the feedback in a way that best suits them, and reinforce memory by repetition | ON if the performance result text was accompanied by a graphical display of performance data OFF when the graphical display was absent |
Specify desired behaviour to facilitate intentions to perform that behaviour and enhance the likelihood of subsequent action | ON if the feedback suggested specific recommendations for action (i.e. who needs to do what, differently, with or to whom, where and when) OFF when such recommendations were absent |
Provide short, actionable messages with optional information available for interested recipients. Feedback credibility can be enhanced if recipients are able to ‘drill down’ to better understand their data | ON if short messages with clickable, expanding links to explanatory detail were included OFF when these links were absent |
Explicitly link patient experience to audit standards to highlight the importance of providing high-quality care and hence increase motivation to improve practice | ON when a box including a photograph of a fictional patient was added, with a quotation describing their experience of care related to the associated audit standard OFF when these were absent |
Minimise the effort required to process information by prioritising key messages, reducing the amount of data presented, improving readability, and reducing visual clutter | ON when distracting detail was minimised OFF if additional general text not directly related to the audit standard and feedback on other audit standards was added |
NCA standards contributing to experiment outcomes
| NCABT | Clinical staff should prescribe tranexamic acid for surgical patients expected to have moderate or more significant blood loss unless contraindicated |
| NDA | Patients with type 2 diabetes whose HbA1c level is 58 mmol/mol (7.5%) or above after 6 months with single-drug treatment are offered dual therapy |
| MINAP | Adults with non-ST-segment-election myocardial infarction or unstable angina who have an intermediate or higher risk of future adverse cardiovascular events are offered coronary angiography (with follow-on percutaneous coronary intervention if indicated) within 72 h of first admission to hospital |
| PICANet | Minimise the number of unplanned extubations for paediatric intensive care patients per 1000 days of invasive ventilation |
| TARN | Patients who have had urgent 3D imaging for major trauma should have a provisional written radiology report within 60 min of the scan |
Fig. 1Experiment summary — participant flow
Participant characteristics, modifications, and experiment completion
| Participant completed experiment | |||
|---|---|---|---|
| Yes ( | No. ( | Total ( | |
| MINAP | 158 (27.9%) | 20 (27.8%) | 178 (27.9%) |
| NCABT | 93 (16.4%) | 9 (12.5%) | 102 (16.0%) |
| NDA | 172 (30.4%) | 32 (44.4%) | 204 (32.0%) |
| PICANet | 33 (5.8%) | 3 (4.2%) | 36 (5.6%) |
| TARN | 110 (19.4%) | 8 (11.1%) | 118 (18.5%) |
| Allied health professional | 39 (6.9%) | 6 (8.3%) | 45 (7.1%) |
| Nurse or nurse specialist | 156 (27.6%) | 13 (18.1%) | 169 (26.5%) |
| Fully trained doctor | 128 (22.6%) | 6 (8.3%) | 134 (21.0%) |
| Training doctor | 3 (0.5%) | 1 (1.4%) | 4 (0.6%) |
| Manager | 141 (24.9%) | 33 (45.8%) | 174 (27.3%) |
| Audit and admin | 99 (17.5%) | 13 (18.1%) | 112 (17.6%) |
| Commissioning | 24 (4.2%) | 3 (4.2%) | 27 (4.2%) |
| Community healthcare trust | 5 (0.9%) | 3 (4.2%) | 8 (1.3%) |
| General practice | 160 (28.3%) | 29 (40.3%) | 189 (29.6%) |
| Hospital trust | 377 (66.6%) | 37 (51.4%) | 414 (64.9%) |
| Missing | 0 | 9 | 9 |
| Median (IQR) | 68.5 (33, 138.5) | 45.0 (23.5, 110.5) | 66.5 (31, 136) |
| Missing | 0 | 9 | 9 |
| Mean (SD) | 2.3 (5.34) | 1.8 (1.50) | 2.2 (5.09) |
| Median (IQR) | 1.0 (1.0, 2.0) | 1.0 (1.0, 2.0) | 1.0 (1.0, 2.0) |
| Missing | 72 | 72 | |
| Median (IQR) | 159 (97.5, 255.5) | 159 (97.5, 255.5) | |
| Yes | 545 (96.3%) | 545 (96.3%) | |
| No | 21 (3.7%) | 21 (3.7%) | |
| On | 292 (51.6%) | 33 (45.8%) | 325 (50.9%) |
| Off | 274 (48.4%) | 39 (54.2%) | 313 (49.1%) |
| On | 289 (51.1%) | 31 (43.1%) | 320 (50.2%) |
| Off | 277 (48.9%) | 41 (56.9%) | 318 (49.8%) |
| On | 284 (50.2%) | 34 (47.2%) | 318 (49.8%) |
| Off | 282 (49.8%) | 38 (52.8%) | 320 (50.2%) |
| On | 273 (48.2%) | 39 (54.2%) | 312 (48.9%) |
| Off | 293 (51.8%) | 33 (45.8%) | 326 (51.1%) |
| On | 280 (49.5%) | 40 (55.6%) | 320 (50.2%) |
| Off | 286 (50.5%) | 32 (44.4%) | 318 (49.8%) |
| On | 278 (49.1%) | 39 (54.2%) | 317 (49.7%) |
| Off | 288 (50.9%) | 33 (45.8%) | 321 (50.3%) |
SD, standard deviation; IQR, interquartile range
Fig. 2Distribution of the primary outcome by NCA and role
Fig. 3Distribution of secondary outcomes
Parameter estimates for parsimonious models across outcomes*
| Parameter | Primary outcome: intention | Proximal intention | Comprehension | User experience | |||
|---|---|---|---|---|---|---|---|
| Attention | Goals | Action plan | Review performance | ||||
| MINAP | |||||||
| NCABT | |||||||
| PICANet | |||||||
| TARN | |||||||
| 0.118 (0.075) | |||||||
| 0.115 (0.089) | |||||||
| 0.078 (0.068) | |||||||
| 0.087 (0.089) | |||||||
| 0.093 (0.09) | |||||||
| | |||||||
| | |||||||
| | |||||||
| | |||||||
| Non-clinical * MINAP | |||||||
| Non-clinical * NCABT | |||||||
| Non-clinical * PICA | |||||||
| Non-clinical * TARN | |||||||
| 0.195 (0.087) | |||||||
| B * NCABT | |||||||
| B * MINAP | |||||||
| B * PICANet | |||||||
| B * TARN | |||||||
| F * NCABT | |||||||
| F * MINAP | |||||||
| F * PICANet | |||||||
| F * TARN | |||||||
| B * F * NCABT | |||||||
| B *F * MINAP | |||||||
| B *F * PICANet | |||||||
| B *F * TARN | |||||||
*The columns identify promising detected effects for each outcome, whilst rows identify consistent effects identified across outcomes. Blank cells represent parameters not included in the model. Parameter estimates are all on the same scale of −3 “completely disagree” to +3 “completely agree”. The model intercept represents the overall predicted mean outcome in the NDA and clinical recipient reference groups, averaged across all possible combinations of modifications. Parameter estimates for NCA and role represent the deviation from the predicted mean outcome for the alternative audit and non-clinical recipients. Positive estimates represent an improvement in outcome compared to the reference NDA and clinical recipients, whereas a negative parameter estimate represents a detrimental effect on outcome. Positive parameter estimates for the main effect of each modification represent an improvement in outcome when the modification is ON (+1) and a negative effect on outcome when the modification is OFF (−1). Conversely, negative parameter estimates represent a negative effect on outcome when the modification is ON (+1) and an improvement in outcome when the modification is OFF (−1). Parameter estimates for interactions between modifications represent the additional deviation from the predicted mean outcome
Fig. 4Primary outcome: Pareto plot of standardised effects (primary outcome, stage-2 full model)
Fig. 5Predicted intention for modification combinations ordered by clinical recipients (results/estimates presented for the NDA only; however, relative effectiveness of modification combinations is consistent across NCAs)